- Home
- ITRM vs EQS Comparison
ITRM vs EQS Comparison
Compare ITRM & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRM
- EQS
- Stock Information
- Founded
- ITRM 2015
- EQS 1991
- Country
- ITRM Ireland
- EQS United States
- Employees
- ITRM N/A
- EQS N/A
- Industry
- ITRM Biotechnology: Pharmaceutical Preparations
- EQS Finance Companies
- Sector
- ITRM Health Care
- EQS Finance
- Exchange
- ITRM Nasdaq
- EQS Nasdaq
- Market Cap
- ITRM 40.0M
- EQS 33.7M
- IPO Year
- ITRM 2018
- EQS N/A
- Fundamental
- Price
- ITRM $0.62
- EQS $1.95
- Analyst Decision
- ITRM Strong Buy
- EQS
- Analyst Count
- ITRM 1
- EQS 0
- Target Price
- ITRM $9.00
- EQS N/A
- AVG Volume (30 Days)
- ITRM 985.2K
- EQS 11.9K
- Earning Date
- ITRM 11-12-2025
- EQS 01-01-0001
- Dividend Yield
- ITRM N/A
- EQS N/A
- EPS Growth
- ITRM N/A
- EQS N/A
- EPS
- ITRM N/A
- EQS N/A
- Revenue
- ITRM N/A
- EQS $1,355,000.00
- Revenue This Year
- ITRM N/A
- EQS N/A
- Revenue Next Year
- ITRM $482.25
- EQS N/A
- P/E Ratio
- ITRM N/A
- EQS N/A
- Revenue Growth
- ITRM N/A
- EQS 60.35
- 52 Week Low
- ITRM $0.61
- EQS $0.74
- 52 Week High
- ITRM $3.02
- EQS $2.49
- Technical
- Relative Strength Index (RSI)
- ITRM 37.35
- EQS 47.70
- Support Level
- ITRM $0.64
- EQS $1.75
- Resistance Level
- ITRM $0.70
- EQS $2.01
- Average True Range (ATR)
- ITRM 0.04
- EQS 0.09
- MACD
- ITRM -0.01
- EQS 0.00
- Stochastic Oscillator
- ITRM 2.20
- EQS 58.28
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.